1-20 of 41
Authors: Xiao-Tang Kong
Journal Article
INNV-01. METASTATIC GLIOBLASTOMA TO THE LUNG TREATED WITH LENVATINIB Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii169, https://doi.org/10.1093/neuonc/noae165.0664
Published: 11 November 2024
Journal Article
NCOG-50. LONG TERM-SURVIVAL OF AN ELDERLY PATIENT WITH GIANT CELL CEREBELLUM GLIOBLASTOMA (GBM) Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii235–viii236, https://doi.org/10.1093/neuonc/noae165.0931
Published: 11 November 2024
Journal Article
CTNI-83. PROPOSAL FOR A PILOT PHASE 1B CLINICAL TRIAL WITH ADDITION OF NATURAL MARINE PRODUCT FUCOIDAN TO ANTI-NEOPLASTIC THERAPY FOR PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM) TO IMPROVE FATIGUE AND OTHER HEALTH-RELATED QUALITY OF LIFE (HRQOL) SYMPTOMS Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii116–viii117, https://doi.org/10.1093/neuonc/noae165.0450
Published: 11 November 2024
Journal Article
PATH-31. COMPLETE TUMOR DISAPPEARANCE ON BRAIN MRI AFTER STANDARD CHEMORADIATION THERAPY FOR A MOLECULAR GLIOBLASTOMA Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii185, https://doi.org/10.1093/neuonc/noae165.0730
Published: 11 November 2024
Journal Article
NIMG-78. THE ROLE OF FDG PET/CT IN MANAGING DIFFUSE MIDLINE GLIOMA WITH H3K27M MUTATION: A CASE STUDY AND PATHOLOGICAL CORRELATION Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii213, https://doi.org/10.1093/neuonc/noae165.0842
Published: 11 November 2024
Journal Article
BIOM-03. DABRAFENIB AND STEROIDS FOR THE TREATMENT OF ERDHEIM-CHESTER DISEASE WITH EXTENSIVE CENTRAL NERVOUS SYSTEM INVOLVEMENT Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii19, https://doi.org/10.1093/neuonc/noae165.0076
Published: 11 November 2024
Journal Article
CTNI-81. PROPOSAL FOR A PHASE IB PILOT CLINICAL TRIAL TO STUDY SAFETY AND IMPROVING ANTI-NEOPLASTIC ADVERSE EFFECTS BY ADDITION OF NATURAL MARINE PRODUCT FUCOIDAN TO THE STANDARD THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii116, https://doi.org/10.1093/neuonc/noae165.0448
Published: 11 November 2024
Journal Article
NCOG-08. A RARE PRIMARY CNS T-CELL LYMPHOMA CASE: 12-YEAR FOLLOW-UP AFTER CHEMOTHERAPY Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii225, https://doi.org/10.1093/neuonc/noae165.0890
Published: 11 November 2024
Journal Article
BIOM-02. A HIGH-GRADE GLIOMA, NOT ELSEWHERE CLASSIFIED IN AN OLDER ADULT WITH DISCORDANT GENETIC AND EPIGENETIC ANALYSES Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii19, https://doi.org/10.1093/neuonc/noae165.0075
Published: 11 November 2024
Journal Article
CTNI-30. A PHASE 2 DOUBLE-BLIND, RANDOMIZED, PROSPECTIVE, PLACEBO CONTROLLED STUDY OF NANO₂TM COMBINED WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA: RESTORE Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii102, https://doi.org/10.1093/neuonc/noae165.0397
Published: 11 November 2024
Journal Article
PATH-24. A CASE SERIES OF LONGER THAN EXPECTED SURVIVAL IN IDH-WILDTYPE, MGMT-UNMETHYLATED GLIOBLASTOMA PATIENTS Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v172–v173, https://doi.org/10.1093/neuonc/noad179.0654
Published: 10 November 2023
Journal Article
INNV-25. PROLONGED FOLLOW-UP OF AN OLIGODENDROGLIOMA PATIENT WITH HISTORY OF TUMOR TREATING FIELDS (TTF) AS POST CHEMO-RADIATION MAINTENANCE THERAPY Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v162, https://doi.org/10.1093/neuonc/noad179.0614
Published: 10 November 2023
Journal Article
NCOG-09. EXAMINING THE CLINICAL UTILITY OF NEXT GENERATION SEQUENCING IN ADULT GLIOBLASTOMA – A SINGLE CENTER RETROSPECTIVE STUDY Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v215, https://doi.org/10.1093/neuonc/noad179.0822
Published: 10 November 2023
Journal Article
INNV-07. ADJUVANT POST-SURGERY TREATMENT OF RECURRENT IDH2 MUTANT ANAPLASTIC OLIGODENTROGLIOMA (AO) WITH IDH2 INHIBITOR, ENASIDENIB: A CASE REPORT Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v157, https://doi.org/10.1093/neuonc/noad179.0597
Published: 10 November 2023
Journal Article
IMMU-54. PNEUMOCYSTIS JIROVECII PNEUMONIA INFECTION IN A PATIENT WITH ANAPLASTIC ASTROCYTOMA AND RADIATION NECROSIS IN THE SETTING OF CORTICOSTEROID AND PEMBROLIZUMAB USE Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v154–v155, https://doi.org/10.1093/neuonc/noad179.0586
Published: 10 November 2023
Journal Article
NCOG-17. RETROSPECTIVE REVIEW OF THE TREATMENT OF VENOUS THROMBOEMBOLISM IN GLIOBLASTOMA PATIENTS RECEIVING BEVACIZUMAB Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v217, https://doi.org/10.1093/neuonc/noad179.0830
Published: 10 November 2023
Journal Article
INNV-21. EXTENDED SURVIVAL OF RECURRENT ANAPLASTIC OLIGODENDROGLIOMA PATIENT WITH GOOD FUNCTIONAL STATUS ON LONG TERM PEMBROLIZUMAB AND BEVACIZUMAB THERAPY - A CASE REPORT Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v161, https://doi.org/10.1093/neuonc/noad179.0610
Published: 10 November 2023
Journal Article
PATH-40. A GIANT CELL LESION RESEMBLING REPARATIVE GIANT CELL GRANULOMA WITH FN1-TEK FUSION, IN THE SPECTRUM OF CALCIFIED CHONDROID MESENCHYMAL NEOPLASM? Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii159, https://doi.org/10.1093/neuonc/noac209.613
Published: 14 November 2022
Journal Article
CTNI-23. PRELIMINARY SAFETY AND PHARMACOKINETICS DATA FOR A PHASE 1B TRIAL OF TELAGLENASTAT IN COMBINATION WITH RADIATION THERAPY AND TEMOZOLOMIDE IN PATIENTS WITH IDH-MUTANT GRADE 2/3 ASTROCYTOMA (NCI-10218) Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii75, https://doi.org/10.1093/neuonc/noac209.288
Published: 14 November 2022
Journal Article
INNV-18. PROLONGED REMISSION AFTER TREATMENT WITH SINGLE-AGENT IBRUTINIB AS MAINTENANCE THERAPY FOLLOWING SALVAGE RADIATION THERAPY FOR REFRACTORY/RELAPSE PRIMARY CNS LYMPHOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii145, https://doi.org/10.1093/neuonc/noac209.558
Published: 14 November 2022
